Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Schwarzmeier

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|December 29, 2004
Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemiaJ D Schwarzmeier, R Hubmann, M Düchler, et al.
Blood|July 27, 1999
Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemiaG Gruber, J D Schwarzmeier, M Shehata, et al.
Onkologie|August 1, 1988
[Mechanism of action of interferon-alpha 2 in hairy cells and lymphoblastoid cell lines: the significance of type I interferon receptors and RNA synthesis]M Schwabe, L Wagner, F Prischl, et al.
Renal Physiology|January 1, 1981
Hormone-sensitive adenylate cyclase in glomerular cells: possible role for inflammatory diseases of the glomerulusE Paietta, J D Schwarzmeier, G Simbruner, et al.
Wiener Klinische Wochenschrift|July 18, 1986
Effects of prednisolone on beta-adrenergic desensitization of normal peripheral lymphocytes: an in vitro model for steroid-controlled tachyphylaxisK Sertl, E Paietta, S Meryn, et al.
Acta Medica Austriaca|January 1, 1979
[Acute myeloid leukemia with chromosome 5 deletion (a new syndrome)]O Haas, J D Schwarzmeier, E Paietta, et al.
Blood|June 1, 1981
Proliferation kinetics of Sézary cellsJ D Schwarzmeier, E Paietta, T Radaszkiewicz, et al.
Blut|January 1, 1984
Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML)O A Haas, J D Schwarzmeier, E Nacheva, et al.
Journal of Biological Response Modifiers|August 1, 1989
Long-term remission in a patient with erythroleukemia following interferon-alpha treatmentG G Steger, C Dittrich, A Chott, et al.
Acta Medica Austriaca|January 1, 1979
[Clinical and laboratory chemical examination in the diagnostic demarkation of chronic lymphatic leukemia]J F Hofer, J D Schwarzmeier, L Marosi, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|December 29, 2004
Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemiaJ D Schwarzmeier, R Hubmann, M Düchler, et al.
Blood|July 27, 1999
Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemiaG Gruber, J D Schwarzmeier, M Shehata, et al.
Onkologie|August 1, 1988
[Mechanism of action of interferon-alpha 2 in hairy cells and lymphoblastoid cell lines: the significance of type I interferon receptors and RNA synthesis]M Schwabe, L Wagner, F Prischl, et al.
Renal Physiology|January 1, 1981
Hormone-sensitive adenylate cyclase in glomerular cells: possible role for inflammatory diseases of the glomerulusE Paietta, J D Schwarzmeier, G Simbruner, et al.
Wiener Klinische Wochenschrift|July 18, 1986
Effects of prednisolone on beta-adrenergic desensitization of normal peripheral lymphocytes: an in vitro model for steroid-controlled tachyphylaxisK Sertl, E Paietta, S Meryn, et al.
Acta Medica Austriaca|January 1, 1979
[Acute myeloid leukemia with chromosome 5 deletion (a new syndrome)]O Haas, J D Schwarzmeier, E Paietta, et al.
Blood|June 1, 1981
Proliferation kinetics of Sézary cellsJ D Schwarzmeier, E Paietta, T Radaszkiewicz, et al.
Blut|January 1, 1984
Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML)O A Haas, J D Schwarzmeier, E Nacheva, et al.
Journal of Biological Response Modifiers|August 1, 1989
Long-term remission in a patient with erythroleukemia following interferon-alpha treatmentG G Steger, C Dittrich, A Chott, et al.
Acta Medica Austriaca|January 1, 1979
[Clinical and laboratory chemical examination in the diagnostic demarkation of chronic lymphatic leukemia]J F Hofer, J D Schwarzmeier, L Marosi, et al.
Pageof 5